Sramana Mitra: How much of system integration work is involved to implement a solution like yours? Ariel Stern: Before Ayyeka, the majority of the projects were system integrations. We said, “Ayyeka will eliminate the need for the complicated system integration. We provide end-to-end solutions that have both the hardware and software.” It’s almost like plug-and-play.
IoT companies have often been system integrators. Ariel discusses an end-to-end solution strategy that includes both hardware and software. Sramana Mitra: Let’s start by introducing our audience to yourself and Ayyeka.
Sramana Mitra: Are all your work sites construction sites? Robert Constantini: We provide solutions across a lot of industries like construction, energy, mining, manufacturing, and heavy industrial. One of the key issues is that the robustness of our technology works in these challenging environments. That’s where our technology shines. Sramana Mitra: I assume COVID has
Robert Constantini: We you use the technology to signal a site-wide evacuation. The wearable itself will notify the worker as well as beacons around the site, which dramatically reduces evacuation times by over 70%. We also monitor equipment utilization and other hazards on site. There’s no price you can put on the potential to avoid
Triax has seen tremendous acceleration due to Covid for its wearables-based IoT technology. Interesting perspective. Sramana Mitra: Let’s start by introducing our audience to yourself as well as Triax. Robert Constantini: I’m the CEO of Triax Technologies for 18 months since the fall of 2019, right before COVID. My background is in Finance and Law. I’ve
Sramana Mitra: Tell me a bit about the company. Is it a funded company? Sridhar Iyengar: We’re venture-backed. We’re a Series A company. We’ve about 35 people in the company right now. Sramana Mitra: Where are you based? Sridhar Iyengar: We’re based in the Greater Boston area, but we have a distributed team.
Sramana Mitra: What level of adoption are we talking about in LabOps as you call it. What is the pace of adoption in this world? Sridhar Iyengar: It really depends on the type of company that we’re working with. I mentioned synthetic biology. These companies were very early adopters because of the need of the
Sramana Mitra: Double-click down on MedTech labs. How exactly does your product play in that environment? Sridhar Iyengar: What we’ve seen in the last 10 years or so is that there’s been a tremendous acceleration of biotech and life science startups. Much more than the decade prior to that. One of the specialties is this